UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors

Oncogene, 2013-06, Vol.32 (26), p.3184-3197

2013

Volltextzugriff (PDF)

KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer

Science (American Association for the Advancement of Science), 2001-12, Vol.294 (5551), p.2563-2566

2001

Volltextzugriff (PDF)

In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma

Oncogene, 2007-06, Vol.26 (30), p.4428-4434

2007

Volltextzugriff (PDF)

The use of novel PP2A activators in combination with PARP inhibitor for the treatment of high-grade serous ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.73-73

2017

Volltextzugriff (PDF)

486 Development of small molecule activators of protein phosphatase 2A for the treatment of lung cancer

European journal of cancer (1990), 2014-11, Vol.50, p.158-159

2014

Volltextzugriff (PDF)

Green synthesis of 1,2,3‐triazoles via Cu2O NPs on hydrogen trititanate nanotubes promoted 1,3‐dipolar cycloadditions

Applied organometallic chemistry, 2019-03, Vol.33 (3), p.n/a

2019

Volltextzugriff (PDF)

Small molecule activators of protein phosphatase 2A for the treatment of endometrial cancer

Gynecologic oncology, 2015-04, Vol.137, p.208-208

2015

Volltextzugriff (PDF)

548 Development of a small molecule activator of protein phosphatase 2A for the treatment of prostate cancer

European journal of cancer (1990), 2014-11, Vol.50, p.178-178

2014

Volltextzugriff (PDF)

E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor

Oncogene, 2006-09, Vol.25 (44), p.6026-6031

2006

Volltextzugriff (PDF)

Quantitative PCR array identification of microRNA clusters associated with epithelial ovarian cancer chemoresistance

Gynecologic oncology, 2011-03, Vol.120, p.S54-S54

2011

Volltextzugriff (PDF)

PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells

Science translational medicine, 2018-07, Vol.10 (450)

2018

Volltextzugriff (PDF)

Bisphosphonates inactivate human EGFRs to exert antitumor actions

Proceedings of the National Academy of Sciences - PNAS, 2014-12, Vol.111 (50), p.17989-17994

2014

Volltextzugriff (PDF)

Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer

Proceedings of the National Academy of Sciences - PNAS, 2014-12, Vol.111 (50), p.17995-18000

2014

Volltextzugriff (PDF)

DYSREGULATION OF TUMOR SUPPRESSOR KLF6 INCREASES HCC RELATED MORTALITY IN HCV INFECTED PATIENTS AND INCIDENCE OF TUMOR IN MOUSE MODEL OF HEPATIC CARCINOGENESIS

Digestive and liver disease, 2009, Vol.41, p.S18-S18

2009

Volltextzugriff (PDF)

The use of novel PP2A activators in combination withPARP inhibitor for the treatment of high-grade serous ovarian cancer

Gynecologic oncology, 2017-06, Vol.145, p.73

2017

Volltextzugriff (PDF)

Krüppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1

The Journal of biological chemistry, 2005-07, Vol.280 (29), p.26941-26952

2005

Volltextzugriff (PDF)

Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (13), p.5761-5768

2005

Volltextzugriff (PDF)

0021: Targeting in Vivo Delivery of Sirnas to Study the Role of Klf6 in Epithelial Ovarian Cancer

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.605-605

2006

Volltextzugriff (PDF)

Mutations in Capillary Morphogenesis Gene-2 Result in the Allelic Disorders Juvenile Hyaline Fibromatosis and Infantile Systemic Hyalinosis

American journal of human genetics, 2003-10, Vol.73 (4), p.957-966

2003

Volltextzugriff (PDF)

Frequent inactivation of the tumor suppressor Kruppel‐like factor 6 (KLF6) in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2004-11, Vol.40 (5), p.1047-1052

2004

Volltextzugriff (PDF)

A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (4), p.1213-1222

2005

Volltextzugriff (PDF)

Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer

Gastroenterology (New York, N.Y. 1943), 2004-04, Vol.126 (4), p.1090-1103

2004

Volltextzugriff (PDF)

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (11), p.3885-3891

2004

Volltextzugriff (PDF)

Functional role of the KLF6 tumour suppressor gene in gastric cancer

European journal of cancer (1990), 2009-03, Vol.45 (4), p.666-676

2009

Volltextzugriff (PDF)

Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer

European journal of cancer (1990), 2008-09, Vol.44 (13), p.1895-1903

2008

Volltextzugriff (PDF)

1 – 25 von 258

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Englisch
(258)
Japanisch
(61)

Erscheinungsjahr

n.n

Thema

Science & Technology
(173)
Life Sciences & Biomedicine
(156)
Humans
(135)
Animals
(77)
Biological And Medical Sciences
(61)
Mice
(47)
Hematology
(46)
Medical Sciences
(44)
Male
(42)
Female
(39)
Biochemistry & Molecular Biology
(31)
Molecular Sequence Data
(31)
Membrane Proteins - Genetics
(30)
Cytoskeletal Proteins
(28)
Neuropeptides
(27)
Proteins
(26)
Membrane Proteins - Metabolism
(25)
Amino Acid Sequence
(23)
Cell Biology
(22)
Fundamental And Applied Biological Sciences. Psychology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors

KLF6, a Candidate Tumor Suppressor Gene Mutated in Prostate Cancer

In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma

The use of novel PP2A activators in combination with PARP inhibitor for the treatment of high-grade serous ovarian cancer

486 Development of small molecule activators of protein phosphatase 2A for the treatment of lung cancer

Green synthesis of 1,2,3‐triazoles via Cu2O NPs on hydrogen trititanate nanotubes promoted 1,3‐dipolar cycloadditions

Small molecule activators of protein phosphatase 2A for the treatment of endometrial cancer

548 Development of a small molecule activator of protein phosphatase 2A for the treatment of prostate cancer

E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor

Quantitative PCR array identification of microRNA clusters associated with epithelial ovarian cancer chemoresistance

PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells

Bisphosphonates inactivate human EGFRs to exert antitumor actions

Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer

DYSREGULATION OF TUMOR SUPPRESSOR KLF6 INCREASES HCC RELATED MORTALITY IN HCV INFECTED PATIENTS AND INCIDENCE OF TUMOR IN MOUSE MODEL OF HEPATIC CARCINOGENESIS

The use of novel PP2A activators in combination withPARP inhibitor for the treatment of high-grade serous ovarian cancer

Krüppel-like Factor-6 Promotes Preadipocyte Differentiation through Histone Deacetylase 3-dependent Repression of DLK1

Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread

0021: Targeting in Vivo Delivery of Sirnas to Study the Role of Klf6 in Epithelial Ovarian Cancer

Mutations in Capillary Morphogenesis Gene-2 Result in the Allelic Disorders Juvenile Hyaline Fibromatosis and Infantile Systemic Hyalinosis

Frequent inactivation of the tumor suppressor Kruppel‐like factor 6 (KLF6) in hepatocellular carcinoma

A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk

Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer

Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1

Functional role of the KLF6 tumour suppressor gene in gastric cancer

Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer

Suchergebnisse filtern